Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2017-10-24 Tx date 2017-10-23 |
$XENE
Xenon Pharmaceuticals Inc. |
Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+11,000 vol |
159,585 | |
Filed 2017-03-14 Tx date 2017-03-13 |
$XENE
Xenon Pharmaceuticals Inc. |
Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+27,500 vol |
148,585 | |
Filed 2016-03-11 Tx date 2016-03-11 |
$XENE
Xenon Pharmaceuticals Inc. |
Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
121,085 | |
Filed 2015-12-21 Tx date 2015-12-18 |
$XENE
Xenon Pharmaceuticals Inc. |
Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
101,085 | |
Filed 2015-09-26 Tx date 2015-09-22 |
$XENE
Xenon Pharmaceuticals Inc. |
Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$13,535
+3,619 vol $3.74 each |
12,105 | |
Filed 2015-09-26 Tx date 2015-09-22 |
$XENE
Xenon Pharmaceuticals Inc. |
Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$16,242
+4,343 vol $3.74 each |
16,448 | |
Filed 2015-09-26 Tx date 2015-09-22 |
$XENE
Xenon Pharmaceuticals Inc. |
Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$9,742
+2,605 vol $3.74 each |
19,053 | |
Filed 2015-09-26 Tx date 2015-09-22 |
$XENE
Xenon Pharmaceuticals Inc. |
Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$8,198
+2,192 vol $3.74 each |
21,245 | |
Filed 2015-09-26 Tx date 2015-09-22 |
$XENE
Xenon Pharmaceuticals Inc. |
Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$16,783
+6,286 vol $2.67 each |
27,531 | |
Filed 2015-09-26 Tx date 2015-09-22 |
$XENE
Xenon Pharmaceuticals Inc. |
Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$1,650
+618 vol $2.67 each |
28,149 | |
Filed 2015-09-26 Tx date 2015-09-22 |
$XENE
Xenon Pharmaceuticals Inc. |
Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-57,370.17
-6,149 vol $9.33 each |
22,000 | |
Filed 2015-09-26 Tx date 2015-09-23 |
$XENE
Xenon Pharmaceuticals Inc. |
Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-36,080
-4,000 vol $9.02 each |
18,000 | |
Filed 2015-09-26 Tx date 2015-09-22 |
$XENE
Xenon Pharmaceuticals Inc. |
Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-411 vol |
116,062 | |
Filed 2015-09-26 Tx date 2015-09-22 |
$XENE
Xenon Pharmaceuticals Inc. |
Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-2,057 vol |
114,005 | |
Filed 2015-09-26 Tx date 2015-09-22 |
$XENE
Xenon Pharmaceuticals Inc. |
Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-1,028 vol |
112,977 | |
Filed 2015-09-26 Tx date 2015-09-22 |
$XENE
Xenon Pharmaceuticals Inc. |
Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-5,144 vol |
107,833 | |
Filed 2015-09-26 Tx date 2015-09-22 |
$XENE
Xenon Pharmaceuticals Inc. |
Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-6,172 vol |
101,661 | |
Filed 2015-09-26 Tx date 2015-09-22 |
$XENE
Xenon Pharmaceuticals Inc. |
Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-3,703 vol |
97,958 | |
Filed 2015-09-26 Tx date 2015-09-22 |
$XENE
Xenon Pharmaceuticals Inc. |
Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-3,115 vol |
94,843 | |
Filed 2015-09-26 Tx date 2015-09-22 |
$XENE
Xenon Pharmaceuticals Inc. |
Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-7,973 vol |
86,870 | |
Filed 2015-09-26 Tx date 2015-09-22 |
$XENE
Xenon Pharmaceuticals Inc. |
Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-785 vol |
86,085 | |
Filed 2015-09-26 Tx date 2015-09-24 |
$XENE
Xenon Pharmaceuticals Inc. |
Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-103,200
-12,000 vol $8.60 each |
6,000 | |
Filed 2015-09-26 Tx date 2015-09-22 |
$XENE
Xenon Pharmaceuticals Inc. |
Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$1,292
+213 vol $6.07 each |
6,316 | |
Filed 2015-09-26 Tx date 2015-09-22 |
$XENE
Xenon Pharmaceuticals Inc. |
Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$5,411
+1,447 vol $3.74 each |
7,763 | |
Filed 2015-09-26 Tx date 2015-09-22 |
$XENE
Xenon Pharmaceuticals Inc. |
Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$2,704
+723 vol $3.74 each |
8,486 | |
Filed 2015-08-20 Tx date 2015-08-18 |
$XENE
Xenon Pharmaceuticals Inc. |
Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$10,822
+1,783 vol $6.07 each |
6,103 | |
Filed 2015-08-20 Tx date 2015-08-18 |
$XENE
Xenon Pharmaceuticals Inc. |
Goldberg, Yigal Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-3,085 vol |
116,473 |